Boston Scientific’s share price — which medical device competitors have long envied — sputtered Feb. 4 after the company ...
Boston Scientific (BSX), a leading global player in medical devices, announced solid Q4 earnings but offered 2026 guidance ...
The medical-device maker beats quarterly earnings expectations but offers a disappointing outlook for the current quarter.
Boston Scientific stock fell 8.4% despite beating Q4 earnings as weak Q1 guidance and electrophysiology division miss ...
Feb 4 (Reuters) - Boston Scientific Corp forecast modest 2026 revenue growth and profit just below Wall Street expectations ...
Boston Scientific Corporation (NYSE: BSX) reported Q4 2025 revenues of $5.29B, beating management guidance and consensus estimate.
Q4 2025 earnings call recap: revenue, EPS beat, 2026 organic growth & guidance, key drivers (EP, WATCHMAN) and risks—read now ...
View Boston Scientific Corporation BSX stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results